Work

Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases

Year: 2016
Type: review
Abstract: Mesenchymal stem cells (MSCs) represent an attractive cell type for research and therapy due to their ability to proliferate, differentiate, modulate immune reactions, and secrete trophic factors. MSCs exist in a multitude of tissues, including bone marrow, umbilical cord, and adipose tissues. Moreover, MSCs have recently been isolated from the liver. Compared with other MSC types, liver-derived human MSCs (LHMSCs) possess general morphologies, immune functions, and differentiation capacities. Interestingly, LHMCSs produce higher levels of pro-angiogenic, anti-inflammatory, and anti-apoptotic cytokines than those of bone marrow-derived MSCs. Thus, these cells may be a promising therapeutic source for liver diseases. This paper summarizes the biological characteristics of LHMSCs and their potential benefits and risks for the treatment of liver diseases.
Language: English
Subfield: Cell Biology
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W2367921402
FWCI: 0.781
Cites: 88
Cited by: 82
Related to: 9